
June 20, 2025
•
1 min read
mTatt Spotlighted in InfoBref
Our CEO and co-founder, Sam Babity, was recently interviewed by InfoBref about mTatt’s innovative home health monitoring solution. In the interview, Sam discussed how our temporary “tattoo” system, combined with a wearable reader and app, allows patients to track key health indicators from home in real time. He also shared insights on our progress toward clinical trials, pilot projects with hospitals, and plans for regulatory approval in Canada and the U.S.
We’re excited to see mTatt’s work recognized and look forward to continuing to innovate in patient-centered healthcare.
About mTatt: mTatt is a health technology startup developing an innovative microneedle patch for continuous, non-invasive monitoring of biomarkers such as hormones, NT-proBNP, cholesterol, and more. Its technology aims to enable real-time health insights, supporting earlier detection, personalized treatment, and improved patient outcomes.
Disclaimer: The mTatt patch is currently under development, has not been approved by regulatory authorities, and is not yet available for sale in any geography.
Contact: Samuel Babity — Co-Founder and CEO
Sources: InfoBref